Skip to main content
. 2022 May 14;11(6):586–596. doi: 10.1093/stcltm/szac024

Figure 2.

Figure 2.

Changes in the VAS for pain and the WOMAC scores for function at 6, 12, 24, 36, 48, and 60 months after intra-articular injection of ADMSCs from baseline (pre-injection) showing that VAS for pain (A), total WOMAC scores (B), pain sub-score of WOMAC (C), and function sub-score of WOMAC (E) had shown significant improvements until 5 years after the injection of ADMSCs. Stiffness sub-sub-score of WOMAC (D) had shown significant improvement until 3 years after the injection of ADMSCs. *Indicates statistically significant difference from baseline (P < .05). Abbreviations: ADMSC, adipose-derived mesenchymal stem cell; F/U, follow-up; VAS, visual analog scale; Western Ontario and McMaster Universities Osteoarthritis Index.